\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ conservative\\ measures\\.\ \(8\)\
\-\ treatment\\ of\\ complications\\ secondary\\ to\\ increased\\ risk\\ of\\ stone\\ formation\\,\\ obstruction\\ and\\ infection\ \(0\)\
\-\ \\â\\€\\¢\\ renal\\ fusion\\ or\\ isthmus\\ crossing\\ aorta\\ at\\ ima\ \(0\)\
\-\ \\â\\€\\¢\\ low\\ position\\ and\\ malrotated\\ \\(anteriorly\\ directed\\ renal\\ pelvis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ enhancing\\/functioning\\ renal\\ isthmus\ \(0\)\
\-\ renal\\ ectopia\\ with\\ horseshoe\\ kidney\ \(0\)\
\-\ \\â\\€\\¢\\ renal\\ ectopia\\-fusion\ \(0\)\
\-\ \\â\\€\\¢\\ lump\\,\\ cake\\,\\ disk\\,\\ or\\ horseshoe\\ kidney\ \(0\)\
\-\ \\â\\€\\¢\\ aberrant\\ arterial\\ supply\\ \\(may\\ cause\\ obstruction\\)\ \(0\)\
\-\ 15\\ y\\.o\\.\\ boy\\ with\\ a\\ history\\ of\\ arachnoid\\ cyst\\ and\\ megacolon\\ \\ \\-\\ now\\ presenting\\ with\\ urinary\\ incontinence\\ over\\ the\\ past\\ year\\.\\ \\ currently\\ complaining\\ of\\ occasional\\ right\\ flank\\ pain\\.\\ \\ reports\\ intermittent\\ hematuria\\.\ \(0\)\
\-\ hematuria\\ as\\ seen\\ in\\ this\\ patient\\ is\\ not\\ necessarily\\ a\\ complication\\ of\\ a\\ horseshoe\\ kidney\\.\\ \\ hematuria\\ may\\ be\\ secondary\\ to\\ stone\\ formation\\ or\\ infection\\ \\-\\ which\\ the\\ patient\\ is\\ at\\ risk\\ for\\ secondary\\ to\\ kidney\\ morphology\\.\\ \\ no\\ stone\\ was\\ identified\\ on\\ this\\ study\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ horseshoe\\:\\ 0\\.11360048416074697\ \(0\)\
\-\ renal\\:\\ 0\\.08558251831526897\ \(0\)\
\-\ stone\\:\\ 0\\.08502340464997325\ \(0\)\
\-\ isthmus\\:\\ 0\\.08334092088673282\ \(0\)\
\-\ hematuria\\:\\ 0\\.08106688978337484\ \(0\)\
\-\ kidney\\:\\ 0\\.08027689213466693\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.06268057406383551\ \(0\)\
\-\ enhancing\\/functioning\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ ectopia\\-fusion\\:\\ 0\\.058770122826443325\ \(0\)\
\-\ cake\\:\\ 0\\.05144604090198926\ \(0\)\
\-\ secondary\\:\\ 0\\.04778059933017615\ \(0\)\
\-\ formation\\:\\ 0\\.047030018576959515\ \(0\)\
\-\ megacolon\\:\\ 0\\.04682505969825629\ \(0\)\
\-\ malrotated\\:\\ 0\\.045797388499407905\ \(0\)\
\-\ ima\\:\\ 0\\.04490717921524442\ \(0\)\
\-\ risk\\:\\ 0\\.04126942196478782\ \(0\)\
\-\ necessarily\\:\\ 0\\.040716454819095256\ \(0\)\
\-\ obstruction\\:\\ 0\\.04017866731452581\ \(0\)\
\-\ crossing\\:\\ 0\\.03758309729079035\ \(0\)\
\-\ ectopia\\:\\ 0\\.03704947923963344\ \(0\)\
\-\ directed\\:\\ 0\\.03401297571508127\ \(0\)\
\-\ morphology\\:\\ 0\\.03401297571508127\ \(0\)\
\-\ incontinence\\:\\ 0\\.033695455388486235\ \(0\)\
\-\ lump\\:\\ 0\\.03324584684984936\ \(0\)\
\-\ infection\\:\\ 0\\.03312022098763743\ \(0\)\
\-\ aberrant\\:\\ 0\\.03205456825822685\ \(0\)\
\-\ supply\\:\\ 0\\.03170050275613386\ \(0\)\
\-\ disk\\:\\ 0\\.030839091212933815\ \(0\)\
\-\ occasional\\:\\ 0\\.030076355538415523\ \(0\)\
\-\ arachnoid\\:\\ 0\\.02862486564611639\ \(0\)\
\-\ anteriorly\\:\\ 0\\.027936970737881515\ \(0\)\
\-\ complication\\:\\ 0\\.027936970737881515\ \(0\)\
\-\ complaining\\:\\ 0\\.027807516832167506\ \(0\)\
\-\ flank\\:\\ 0\\.026798185855798382\ \(0\)\
\-\ urinary\\:\\ 0\\.026371373464032174\ \(0\)\
\-\ fusion\\:\\ 0\\.025410480786806928\ \(0\)\
\-\ may\\:\\ 0\\.024991044918641653\ \(0\)\
\-\ arterial\\:\\ 0\\.024935630724884476\ \(0\)\
\-\ aorta\\:\\ 0\\.024453492981020303\ \(0\)\
\-\ intermittent\\:\\ 0\\.024453492981020303\ \(0\)\
\-\ \\-\\:\\ 0\\.024423046116111517\ \(0\)\
\-\ measures\\:\\ 0\\.024376420831679797\ \(0\)\
\-\ position\\:\\ 0\\.023720153679591446\ \(0\)\
\-\ presenting\\:\\ 0\\.023218664204674194\ \(0\)\
\-\ reports\\:\\ 0\\.02296586930559224\ \(0\)\
\-\ conservative\\:\\ 0\\.022752273613961458\ \(0\)\
\-\ 15\\:\\ 0\\.0227223110167092\ \(0\)\
\-\ complications\\:\\ 0\\.022574485300080382\ \(0\)\
\-\ currently\\:\\ 0\\.022574485300080382\ \(0\)\
\-\ pelvis\\:\\ 0\\.020700609377277527\ \(0\)\
\-\ n\\/a\\:\\ 0\\.02063471098239391\ \(0\)\
\-\ identified\\:\\ 0\\.020356446941242144\ \(0\)\
\-\ or\\:\\ 0\\.02003045497927415\ \(0\)\
\-\ now\\:\\ 0\\.019474103931344317\ \(0\)\
\-\ boy\\:\\ 0\\.019364811866173143\ \(0\)\
\-\ cause\\:\\ 0\\.019275084177013107\ \(0\)\
\-\ study\\:\\ 0\\.01874420904573306\ \(0\)\
\-\ past\\:\\ 0\\.018101329812976227\ \(0\)\
\-\ y\\.o\\:\\ 0\\.016442529550578\ \(0\)\
\-\ low\\:\\ 0\\.015841120352442666\ \(0\)\
\-\ at\\:\\ 0\\.015436842037755107\ \(0\)\
\-\ cyst\\:\\ 0\\.015309140906840685\ \(0\)\
\-\ over\\:\\ 0\\.014504283934266417\ \(0\)\
\-\ increased\\:\\ 0\\.013936565211997706\ \(0\)\
\-\ this\\:\\ 0\\.012815162844188441\ \(0\)\
\-\ treatment\\:\\ 0\\.011530779730672581\ \(0\)\
\-\ patient\\:\\ 0\\.011421225745551841\ \(0\)\
\-\ seen\\:\\ 0\\.011257517433784602\ \(0\)\
\-\ which\\:\\ 0\\.010634297248283658\ \(0\)\
\-\ \\(\\:\\ 0\\.009631489683251475\ \(0\)\
\-\ \\)\\:\\ 0\\.009513835894844069\ \(0\)\
\-\ be\\:\\ 0\\.008785044822292861\ \(0\)\
\-\ as\\:\\ 0\\.00861718337262752\ \(0\)\
\-\ to\\:\\ 0\\.008541362168859725\ \(0\)\
\-\ not\\:\\ 0\\.008232124478279569\ \(0\)\
\-\ a\\:\\ 0\\.007931996036372025\ \(0\)\
\-\ history\\:\\ 0\\.007868096918047223\ \(0\)\
\-\ is\\:\\ 0\\.007497210378463009\ \(0\)\
\-\ \\,\\:\\ 0\\.007218935080460997\ \(0\)\
\-\ pain\\:\\ 0\\.0069573877835382315\ \(0\)\
\-\ was\\:\\ 0\\.006588516814757912\ \(0\)\
\-\ year\\:\\ 0\\.006374035128486099\ \(0\)\
\-\ right\\:\\ 0\\.006010878060736111\ \(0\)\
\-\ no\\:\\ 0\\.005736294338025347\ \(0\)\
\-\ for\\:\\ 0\\.004860720990951434\ \(0\)\
\-\ on\\:\\ 0\\.004825940082436187\ \(0\)\
\-\ of\\:\\ 0\\.0038834600265996145\ \(0\)\
\-\ and\\:\\ 0\\.0036001801146443692\ \(0\)\
\-\ in\\:\\ 0\\.0028093148676016995\ \(0\)\
\-\ with\\:\\ 0\\.002340083521797795\ \(0\)\
\-\ \\.\\:\\ 0\\.001893308591858468\ \(0\)\
\-\ the\\:\\ 0\\.001843323796048344\ \(0\)\
